Pellesi L, Edvinsson L
J Headache Pain. 2025; 26(1):22.
PMID: 39891050
PMC: 11786519.
DOI: 10.1186/s10194-025-01959-8.
Olesen J
J Headache Pain. 2024; 25(1):222.
PMID: 39701954
PMC: 11656563.
DOI: 10.1186/s10194-024-01903-2.
Edvinsson J, Grubor I, Maddahi A, Edvinsson L
J Headache Pain. 2024; 25(1):216.
PMID: 39663536
PMC: 11633024.
DOI: 10.1186/s10194-024-01933-w.
Degel C, Zitelli K, Zapata J, Nassi J, Botta P
Synapse. 2024; 78(6):e70001.
PMID: 39567365
PMC: 11578939.
DOI: 10.1002/syn.70001.
Kim H, Chung K, Xing J, Kim H, Youn D
Int J Mol Sci. 2024; 25(20).
PMID: 39457088
PMC: 11508441.
DOI: 10.3390/ijms252011306.
Meningeal brain borders and migraine headache genesis.
Christensen S, Levy D
Trends Neurosci. 2024; 47(11):918-932.
PMID: 39304416
PMC: 11563857.
DOI: 10.1016/j.tins.2024.08.012.
Brain-wide mapping of c-Fos expression in nitroglycerin-induced models of migraine.
Xiao S, Lu G, Liu J, Su W, Li C, Liu Y
J Headache Pain. 2024; 25(1):136.
PMID: 39169303
PMC: 11337778.
DOI: 10.1186/s10194-024-01837-9.
VPAC1 and VPAC2 receptors mediate tactile hindpaw hypersensitivity and carotid artery dilatation induced by PACAP38 in a migraine relevant mouse model.
Guo S, Rasmussen R, Hay-Schmidt A, Ashina M, Asuni A, Jensen J
J Headache Pain. 2024; 25(1):126.
PMID: 39085771
PMC: 11293201.
DOI: 10.1186/s10194-024-01830-2.
Provocation of attacks to discover migraine signaling mechanisms and new drug targets: early history and future perspectives - a narrative review.
Olesen J
J Headache Pain. 2024; 25(1):105.
PMID: 38902612
PMC: 11188241.
DOI: 10.1186/s10194-024-01796-1.
Molecular nociceptive mechanisms in migraine: The migraine cascade.
Guo S, Christensen S, Al-Karagholi M, Olesen J
Eur J Neurol. 2024; 31(8):e16333.
PMID: 38894592
PMC: 11235602.
DOI: 10.1111/ene.16333.
Environmental enrichment alleviates hyperalgesia by modulating central sensitization in a nitroglycerin-induced chronic migraine model of mice.
Wang L, Liu X, Zhu C, Wu S, Li Z, Jing L
J Headache Pain. 2024; 25(1):74.
PMID: 38724948
PMC: 11083806.
DOI: 10.1186/s10194-024-01779-2.
Orexins and primary headaches: an overview of the neurobiology and clinical impact.
Stanyer E, Hoffmann J, Holland P
Expert Rev Neurother. 2024; 24(5):487-496.
PMID: 38517280
PMC: 11034548.
DOI: 10.1080/14737175.2024.2328728.
Migraine Comorbidities.
Cuciureanu D, Bistriceanu C, Vulpoi G, Cuciureanu T, Antochi F, Roceanu A
Life (Basel). 2024; 14(1).
PMID: 38255689
PMC: 10820535.
DOI: 10.3390/life14010074.
Mast-cell-specific receptor mediates alcohol-withdrawal-associated headache in male mice.
Son H, Zhang Y, Shannonhouse J, Ishida H, Gomez R, Kim Y
Neuron. 2023; 112(1):113-123.e4.
PMID: 37909038
PMC: 10843090.
DOI: 10.1016/j.neuron.2023.09.039.
Genetic Mechanisms of Migraine: Insights from Monogenic Migraine Mutations.
Gosalia H, Karsan N, Goadsby P
Int J Mol Sci. 2023; 24(16).
PMID: 37628876
PMC: 10454024.
DOI: 10.3390/ijms241612697.
The Role of Glial Cells in Different Phases of Migraine: Lessons from Preclinical Studies.
Vila-Pueyo M, Gliga O, Gallardo V, Pozo-Rosich P
Int J Mol Sci. 2023; 24(16).
PMID: 37628733
PMC: 10454125.
DOI: 10.3390/ijms241612553.
Migraine Treatment: Towards New Pharmacological Targets.
Silvestro M, Iannone L, Orologio I, Tessitore A, Tedeschi G, Geppetti P
Int J Mol Sci. 2023; 24(15).
PMID: 37569648
PMC: 10418850.
DOI: 10.3390/ijms241512268.
Molecular Mechanisms of Migraine: Nitric Oxide Synthase and Neuropeptides.
Karsan N, Gosalia H, Goadsby P
Int J Mol Sci. 2023; 24(15).
PMID: 37569369
PMC: 10418996.
DOI: 10.3390/ijms241511993.
Second messenger signalling bypasses CGRP receptor blockade to provoke migraine attacks in humans.
Do T, Deligianni C, Amirguliyev S, Snellman J, Lopez C, Al-Karagholi M
Brain. 2023; 146(12):5224-5234.
PMID: 37540009
PMC: 10690017.
DOI: 10.1093/brain/awad261.
Debate: differences and similarities between tension-type headache and migraine.
Onan D, Younis S, Wellsgatnik W, Farham F, Andruskevicius S, Abashidze A
J Headache Pain. 2023; 24(1):92.
PMID: 37474899
PMC: 10360340.
DOI: 10.1186/s10194-023-01614-0.